Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Bullock_2002_Int.J.Clin.Pract_56_206

Reference

Title: The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis
Bullock R
Ref: Int J Clin Pract, 56:206, 2002 : PubMed

        



Related information



Citations formats

Bullock R (2002)
The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis
Int J Clin Pract 56: 206-14

Bullock R (2002)
Int J Clin Pract 56: 206-14



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer